Modified risk tobacco product (MRTP) claim, nicotine strength and nicotine label on ZYN perceptions and use intentions among adults who are currently smoking cigarettes
- 3 April 2026
- journal article
- Published by BMJ in Tobacco Control
Abstract
Background: On 17 June 2025, the U.S. Food and Drug Administration (FDA) filed a scientific review for modified risk tobacco product (MRTP) applications from Swedish Match USA for 20 ZYN oral nicotine pouches. This study aims to provide a timely test of the MRTP claim to inform the FDA’s decision-making, by examining the effects of the claim on risk and benefit perceptions, intentions to use ZYN to cut down on cigarettes and intentions to switch completely from cigarettes to ZYN among adults who are currently smoking cigarettes. The study also examined how nicotine strength and label impact ZYN perceptions and intentions. Methods: We recruited 485 adults who were currently smoking cigarettes and conducted a 2 (MRTP claim: present, absent) by 2 (nicotine strength: 3 mg, 6 mg) by 2 (nicotine label: ‘tobacco-free nicotine’, ‘nicotine’) between-subjects experiment with a control condition. Multivariate analyses and logistic regressions examined the impact of the MRTP claim on risk and benefit perceptions, relative risk perceptions and use and complete switch intentions of ZYN, as well as the impact of nicotine strength and nicotine label on perceptions and intentions. Results: MRTP claim led to higher benefit perceptions of ZYN and greater odds of perceiving ZYN as less harmful than cigarettes. ZYN with 3 mg nicotine and the ‘tobacco-free nicotine’ label were associated with greater odds of perceiving ZYN as less harmful. Ethnicity and ZYN use status moderated the impact of message features. The impact of each message feature on use and complete switch intentions was non-significant. Conclusions: The proposed MRTP claim may have limited effectiveness in nudging switching from cigarettes to ZYN among adults who currently smoke. More education is needed to better inform people of ZYN health harm and nicotine risks.Keywords
This publication has 34 references indexed in Scilit:
- Nicotine Pouch Use and Intentions to Quit Cigarette Smoking Among U.S. AdultsJournal of Prevention, 2025
- The Influence of the US FDA Authorized Modified Exposure Claim on Heuristic Processing of Tobacco Risk Information and Marketing Message Among Young AdultsHealth Communication, 2025
- CONSORT 2025 statement: updated guideline for reporting randomized trialsNature Medicine, 2025
- Factors associated with intentions to quit vaping and quit attempts among Adolescents: A structural equation modeling approachAddictive Behaviors, 2024
- Tobacco Free Nicotine Vaping Products: A Study of Health Halo Effects Among Middle School YouthJournal of Health Communication, 2023
- “Tobacco-free” Nicotine Pouches: Risk Perceptions, Awareness, Susceptibility, and Use Among Young Adults in the United StatesNicotine & Tobacco Research, 2022
- Exposure to e-cigarette health claims and association with e-cigarette use and risk perceptions: A cohort study of young adultsAddictive Behaviors, 2022
- Chemical characterization of tobacco-free “modern” oral nicotine pouches and their position on the toxicant and risk continuumsDrug and Chemical Toxicology, 2021
- Determinants of Breast Self-Examination Performance Among Iranian Women: An Application of the Health Belief ModelJournal of Cancer Education, 2010
- What young people want to know when: Effects of mastery and ability goals on interest in different kinds of social comparisons.Journal of Personality and Social Psychology, 1992